Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Machine Learning Classifiers for Predictive Biomarkers Combining Clinical and Radiomic Data in Testicular Cancer

Version 1 : Received: 18 October 2023 / Approved: 18 October 2023 / Online: 18 October 2023 (11:52:35 CEST)

A peer-reviewed article of this Preprint also exists.

Lisson, C.S.; Manoj, S.; Wolf, D.; Lisson, C.G.; Schmidt, S.A.; Beer, M.; Thaiss, W.; Bolenz, C.; Zengerling, F.; Goetz, M. Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer. Cancers 2023, 15, 5630. Lisson, C.S.; Manoj, S.; Wolf, D.; Lisson, C.G.; Schmidt, S.A.; Beer, M.; Thaiss, W.; Bolenz, C.; Zengerling, F.; Goetz, M. Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer. Cancers 2023, 15, 5630.

Abstract

Radiomics refers to the extraction and analysis of a wide range of medical imaging features in a non-invasive and cost-effective manner to comprehensively characterise tumours. In this study, machine learning models combining radiomics and clinical factors were developed to predict retroperitoneal lymph node metastasis in testicular germ cell tumours (TGCTs), with the aim of reducing unnecessary treatment in this group of young patients. Ninety-one patients with surgically proven testicular germ cell tumours and contrast-enhanced CT were included in this retrospective study. After segmenting 273 retroperitoneal lymph nodes using dedicated radiomics software, we developed machine-learning prediction models using Random Forest (RF), Light Gradient Boosting Machine (LGBM), Support Vector Machine Classifier (SVC), and K-Nearest Neighbours (KNN). For each classifier, we developed a radiomics-only, clinical-only, and combined radiomics-clinical prediction model. The models’ performances were evaluated using the area under the receiver operating characteristic curves (AUCs). The RF-based combined clinical and radiomic model showed the most robust performance in predicting LNM with an area under the curve (AUC) of 0.95 (±0.03; 95% CI), accuracy 87%, precision 89%, recall 86% and F1 score 87%, followed by the LGBM model with an area under the curve (AUC) of 0.93 (±0.05; 95% CI), accuracy 83%, precision 87%, recall 80% and F1 score 82%. Decision curve analysis demonstrated the clinical utility of our proposed RF-based combined clinical–radiomics model. Our study has identified reliable and predictive machine-learning techniques for predicting lymph node metastasis in early-stage testicular cancer. Identifying the most effective machine-learning approaches for predictive analysis based on radiomics integrating clinical risk factors can expand the applicability of radiomics in precision oncology and cancer treatment. Multi-centre validation is required to provide high-quality evidence for clinical application.

Keywords

machine learning; testicular cancer; personalised oncology; precision imaging

Subject

Medicine and Pharmacology, Urology and Nephrology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.